Tempest Therapeutics Inc

NASDAQ:TPST   3:59:54 PM EDT
14.41
-0.70 (-4.63%)
Earnings Announcements

Tempest Reports Second Quarter 2021 Financial Results And Provides Corporate Highlights

Published: 08/12/2021 20:15 GMT
Tempest Therapeutics Inc (TPST) - Tempest Reports Second Quarter 2021 Financial Results and Provides Corporate Highlights.
Q2 Loss per Share $7.63.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.10

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.18

More details on our Analysts Page.